Fibrosis-4 score for screening of metabolic dysfunction-associated steatotic liver disease (MASLD): Data from a population-based sample in Tuscany-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fibrosis-4 score for screening of metabolic dysfunction-associated steatotic liver disease (MASLD): Data from a population-based sample in Tuscany

Published:2024-10 Issue:10 Volume:34 Page:2405-2408
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

Silverii Giovanni Antonio^ORCID,Profili Francesco^ORCID,Francesconi Paolo^ORCID,Mannucci Edoardo^ORCID

Publisher

Elsevier BV

Reference18 articles.

1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature;Rinella;J Hepatol,2023

2. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies;Stefan;Lancet Diabetes Endocrinol,2019

3. Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals;Chan;J Clin Endocrinol Metabol,2022

4. American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings;Cusi;Endocr Pract,2022

5. An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH;Tacke;J Hepatol,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP